Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Acute mitogen-activated protein kinase 1/2 inhibition improves functional recovery and vascular changes after ischaemic stroke in rat-monitored by 9.4 T magnetic resonance imaging

Research output: Contribution to journalJournal articlepeer-review

DOI

  1. High-intensity interval training improves insulin sensitivity in older individuals

    Research output: Contribution to journalJournal articlepeer-review

  2. Physiological role of taurine--from organism to organelle

    Research output: Contribution to journalReviewpeer-review

  3. Mortality and morbidity in different immunization protocols for experimental autoimmune myocarditis in rats

    Research output: Contribution to journalJournal articlepeer-review

  1. Could Experimental Inflammation Provide Better Understanding of Migraines?

    Research output: Contribution to journalReviewpeer-review

  2. Identifying molecular targets in trigeminal nociception

    Research output: Contribution to journalComment/debatepeer-review

  3. Repair-related molecular changes during recovery phase of ischemic stroke in female rats

    Research output: Contribution to journalJournal articlepeer-review

  4. Changes in P2Y6 receptor-mediated vasoreactivity following focal and global ischemia

    Research output: Contribution to journalJournal articlepeer-review

  5. Ny medicin beskytter hjernen ved voldsomme hjerneblødninger hos rotter og hunde - nu bliver den testet på danske patienter

    Research output: Contribution to journalContribution to newspaper - Newspaper article

View graph of relations

AIM: The aim was to evaluate the beneficial effect of early mitogen-activated protein kinase (MEK)1/2 inhibition administered at a clinical relevant time-point using the transient middle cerebral artery occlusion model and a dedicated rodent magnetic resonance imaging system (9.4T) to monitor cerebrovascular changes non-invasively for 2 weeks.

METHOD: Transient middle cerebral artery occlusion was induced in male rats for two hours followed by reperfusion. The specific MEK1/2 inhibitor U0126 was administered ip at 6 and 24 hours post-reperfusion. Neurological functions were evaluated by 6- and 28-point tests. 9.4 T magnetic resonance imaging was used to monitor morphological infarct changes at day 2, 8 and 14 after stroke and to evaluate cerebral perfusion at day 14. Immunohistochemistry evaluation of Ki67 was performed 14 days post-stroke.

RESULTS: U0126 improved long-term behavioural outcome and significantly reduced infarct size. In addition, cerebral perfusion in U0126-treated animals was improved compared to the vehicle group. Immunohistochemistry showed a significant increase in Ki67+ cells in U0126-treated animals compared to the vehicle group.

CONCLUSION: Early MEK1/2 inhibition improves long-term functional outcome, promotes recovery processes after stroke and most importantly provides a realistic time window for therapy.

Original languageEnglish
JournalActa Physiologica (Online)
Volume223
Issue number1
Pages (from-to)e12985
ISSN1748-1716
DOIs
Publication statusPublished - 2018
Externally publishedYes

    Research areas

  • Journal Article

ID: 53670508